Population
Scrub typhus patient sera
Design
Preclinical
Authors
Loading...
Cross-reactivity with hHtrA1 may signal autoimmune risk for Orientia vaccines; leaves open need for human safety validation.
The 47-kDa antigen of Orientia tsutsugamushi exhibits cross-reactivity with human serine protease HtrA1, raising safety concerns for its use as a vaccine candidate due to potential autoimmune responses.
Chen et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: